GENE ONLINE|News &
Opinion
Blog

Keytruda
Cancer Vaccine
Moderna and Merck’s mRNA Cancer Vaccine Cuts Melanoma Recurrence by 49%
2026-01-21
FDA Approves PADCEV and Keytruda Perioperative Therapy: A Game-Changer for Cisplatin-Ineligible Bladder Cancer Patients
2025-11-27
New Combo Therapy Shows Major Survival Gains in Cisplatin-Ineligible Bladder Cancer
2025-08-13
MerckPatent
Merck Faces Patent Battle with Halozyme Over Latest Keytruda Injection
2025-03-09
MerckKeytruda
Merck’s Multi-Billion-Dollar KEYTRUDA Levels Up with Novel Subcutaneous Delivery, Matching IV Efficacy
2024-11-22
ESMO 2024 highlights
Highlights from ESMO 2024: Key Oncology Advances from Major Pharmaceutical Companies
2024-09-19
MerckKeytruda
Merck’s KEYTRUDA Fails in Early-Stage Lung and Skin Cancer Trials, Ends Two Phase 3 Studies
2024-08-30
Ranking & Reports MerckQ2 Report
Merck Reports Robust Q2 Growth and Expands Drug Portfolio
2024-08-06
Editors' Picks weekly highlights
GeneOnline’s Weekly News Highlights: Oct 16-Oct 20
2023-10-24
ASCOOncology
2023 ASCO Annual Meeting: Progress in Solid Tumor Treatment Research, and Promising Results in Emerging Therapies
2023-07-03
Trials & Approvals ModernaCancer Vaccine
Moderna’s Cancer Vaccine to Enter Phase 3 Trials This Year
2023-04-17
Trials & Approvals KeytrudaLenvima
Merck, Eisai’s Keytruda-Lenvima Combo Fails in Melanoma and Colorectal Cancer Trials
2023-04-10
Trials & Approvals Keytruda
Merck’s Keytruda Falls Short In Two Trials
2023-03-01
Keytruda
Antengene To Pair CD73 Inhibitor With Merck’s Keytruda In Clinical Collaboration
2022-12-27
Keytruda
Moderna Gets $250 Million from MSD in Personal Cancer Vaccine Licensing Option
2022-10-12
1 2 3
LATEST
David vs. Goliath: Taiwan’s PGI Wins $23M Settlement in Sequencing Patent Dispute with U.S. PacBio
2026-03-13
Gut Microbiome Composition Predicts Long-term Cardiometabolic Health Outcomes in Diverse Urban Populations
2026-03-12
NVIDIA Ahead of GTC 2026: Markets Focus on Data Center Strength, PC Expansion, and the Next Technical Breakout
2026-03-12
Global and APAC Biopharma Watch: Capital Raising, Clinical Expansion, and Industry Moves in Focus
2026-03-12
Dividend Exchange Rate for Q3 2025 Announced by DEC on March 12, 2026
2026-03-12
NewHydrogen Files International Patent Application for ThermoLoop Technology to Enhance Hydrogen Production Efficiency
2026-03-12
BioGene Therapeutics Inc. Appoints Raj S. Pruthi as Director
2026-03-12
READ MORE
EVENT
2026-03-23
DCAT Week
New York, USA
2026-03-23
BIO Europe Spring (Biotech Partnering)
Lisbon, Portugal
2026-03-23
29th European Biotechnology Congress (Biotech R&D)
Rome, Italy
2026-04-09
4th Cell & Gene Therapy Innovation & Access Congress: Asia (Media Partnership)
Seoul, South Korea
2026-04-17
AACR Annual Meeting 2026 (Cancer Research & Early-Stage Breakthroughs)
San Diego, California
2026-04-29
BIO Korea 2026 (R&D & Collaborations)
Seoul, South Korea
SEE MORE
Scroll to Top